Abstract: Linkers for the connection of a therapeutic to another moiety, such as an Fc region of an antibody. Linkers with two or more maleimide functional groups which can undergo nucleophilic conjugate addition reactions. Methods of increasing the duration of action of a therapeutic by attaching to a novel linker and an Fc region of an antibody. Antibody-Drug conjugates, which have increased duration of action over the drug alone.
| # | Name | Date |
|---|---|---|
| 1 | 202517070911-STATEMENT OF UNDERTAKING (FORM 3) [25-07-2025(online)].pdf | 2025-07-25 |
| 2 | 202517070911-Sequence Listing in txt [25-07-2025(online)].txt | 2025-07-25 |
| 3 | 202517070911-Sequence Listing in PDF [25-07-2025(online)].pdf | 2025-07-25 |
| 4 | 202517070911-REQUEST FOR EXAMINATION (FORM-18) [25-07-2025(online)].pdf | 2025-07-25 |
| 5 | 202517070911-PRIORITY DOCUMENTS [25-07-2025(online)].pdf | 2025-07-25 |
| 6 | 202517070911-POWER OF AUTHORITY [25-07-2025(online)].pdf | 2025-07-25 |
| 7 | 202517070911-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [25-07-2025(online)].pdf | 2025-07-25 |
| 8 | 202517070911-FORM 18 [25-07-2025(online)].pdf | 2025-07-25 |
| 9 | 202517070911-FORM 1 [25-07-2025(online)].pdf | 2025-07-25 |
| 10 | 202517070911-DECLARATION OF INVENTORSHIP (FORM 5) [25-07-2025(online)].pdf | 2025-07-25 |
| 11 | 202517070911-COMPLETE SPECIFICATION [25-07-2025(online)].pdf | 2025-07-25 |
| 12 | 202517070911-MARKED COPIES OF AMENDEMENTS [28-07-2025(online)].pdf | 2025-07-28 |
| 13 | 202517070911-FORM 13 [28-07-2025(online)].pdf | 2025-07-28 |
| 14 | 202517070911-AMMENDED DOCUMENTS [28-07-2025(online)].pdf | 2025-07-28 |
| 15 | 202517070911-Proof of Right [15-09-2025(online)].pdf | 2025-09-15 |